79.55
0.15 (0.19%)
| Previous Close | 79.40 |
| Open | 79.38 |
| Volume | 2,236,506 |
| Avg. Volume (3M) | 2,131,927 |
| Market Cap | 4,658,734,592 |
| Price / Earnings (Forward) | 333.33 |
| Price / Sales | 5.24 |
| Price / Book | 6.99 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -13.68% |
| Operating Margin (TTM) | -4.34% |
| Diluted EPS (TTM) | -1.35 |
| Quarterly Revenue Growth (YOY) | 21.40% |
| Total Debt/Equity (MRQ) | 7.53% |
| Current Ratio (MRQ) | 1.77 |
| Operating Cash Flow (TTM) | 14.18 M |
| Levered Free Cash Flow (TTM) | 86.61 M |
| Return on Assets (TTM) | -3.21% |
| Return on Equity (TTM) | -17.72% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Inari Medical, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Average | -0.25 |
|
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 8.54% |
| % Held by Institutions | 95.51% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |